Publications by authors named "Nathan Brendish"

Claim this Profile
R
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.
Navin Venkatraman, Daniel Silman, Duncan Bellamy, Lisa Stockdale, Georgina Bowyer, Nathan Brendish

Lancet Microbe· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two rapid host-response tests for distinguishing bacterial and viral infection in adults with acute respiratory infection.
Bilge Eylem Dedeoglu, Alex R Tanner, Nathan J Brendish, Helen E Moyses, Tristan W Clark

J Infect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world performance of a single-use, analyser-free, molecular point-of-care test for COVID-19 used in the emergency department: Results of a prospective trial (ED-POC).
Mary E Chapman, Nathan J Brendish, Matthew Morris, C Mirella Spalluto, Christopher J McCormick

J Infect· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Rapid Respiratory Virus Testing in Emergency Departments: A Systematic Review and Meta-Analysis.
Tilmann Schober, Kimberly Wong, Gaëlle DeLisle, Chelsea Caya, Nathan J Brendish

JAMA Intern Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation.
Nathan J Brendish, Cai Davis, Mary E Chapman, Florina Borca, Daniel Waddington

J Infect· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial.
Nathan J Brendish, Kate R Beard, Ahalya K Malachira, Alex R Tanner, Langizya Sanga-Nyirongo

Lancet Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19.
Rebekah Penrice-Randal, Xiaofeng Dong, Andrew George Shapanis, Aaron Gardner, Nicholas Harding, Nathan J Brendish

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department.
Christopher T Mansbridge, Alex R Tanner, Kate R Beard, Florina Borca, Hang T T Phan, Nathan J Brendish

Infect Control Hosp Epidemiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department - ADDENDUM.
Christopher T Mansbridge, Alex R Tanner, Kate R Beard, Florina Borca, Hang T T Phan, Nathan J Brendish

Infect Control Hosp Epidemiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study.
Nathan J Brendish, Alex R Tanner, Stephen Poole, Kate R Beard, Vasanth V Naidu

Infect Dis Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19.
Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, Andres F Vallejo, Stephen Poole, Nathan J Brendish

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19.
Robert Livingstone, Hlaing Lin, Nathan J Brendish, Stephen Poole, Alex R Tanner

J Infect· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries.
Maria Victoria Humbert, Precious Chinonyerem Opurum, Nathan J Brendish, Stephen Poole, Peijun He

J Infect· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
Hans de Graaf, Ruth O Payne, Iona Taylor, Kazutoyo Miura, Carol A Long, Nathan J Brendish

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance.
Alex R Tanner, Nathan J Brendish, Stephen Poole, Jessica Pregon, Tristan W Clark

J Infect· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death.
Alex R Tanner, Hang Phan, Nathan J Brendish, Florina Borca, Kate R Beard

J Infect· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Angela M Minassian, Sarah E Silk, Jordan R Barrett, Carolyn M Nielsen, Kazutoyo Miura, Nathan J Brendish

Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial.
Tristan W Clark, Kate R Beard, Nathan J Brendish, Ahalya K Malachira, Samuel Mills

Lancet Respir Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza vaccination: protecting the most vulnerable.
Alex R Tanner, Robert B Dorey, Nathan J Brendish, Tristan W Clark

Eur Respir Rev· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection.
Nathan J Brendish, Stephen Poole, Vasanth V Naidu, Christopher T Mansbridge, Nicholas Norton

J Infect· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.
Nathan J Brendish, Stephen Poole, Vasanth V Naidu, Christopher T Mansbridge, Nicholas J Norton

Lancet Respir Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study.
Stephen Poole, Nathan J Brendish, Tristan W Clark

J Infect· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus.
Stephen Poole, Nathan J Brendish, Alex R Tanner, Tristan W Clark

Lancet Respir Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19.
Tristan W Clark, Nathan J Brendish, Stephen Poole, Vasanth V Naidu, Christopher Mansbridge

J Infect· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care 'test-and-treat' strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol.
Kate Beard, Nathan Brendish, Ahalya Malachira, Samuel Mills, Cathleen Chan

BMJ Open· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis